Спайдер торгуется на премаркете выше вчерашнего закрытия регулярной торговой сессии.
- Европейские индексы изменяются разнонаправленно.
- Nikkei +2.2 %, Shanghai — закрыт.
(внутридневной график) рост на премаркете. Сопротивление 156.00. Поддержка: 155.25-155.50
Ожидаемая макроэкономическая статистика:
In reaction to strong earnings/guidance:
- March Challenger Job Cuts (7:30am)- Prior 7.0%
- Initial Claims (8:30am)- Briefing.com consensus 345K
- Natural Gas Inventories (10:30am)
Financial related names showing strength:
ING +5% (upgraded to Outperform from Neutral at Exane BNP Paribas ), RBS +4.3%, ING +3.6%, BBVA +2%, SAN +1.9%, DB +1.8% (derivatives portfolio is being probed by German regulators, according to reports ), BCS +1.3%, BAC +0.8%, JPM +0.7%, C +0.7%, HBC +0.3%.
Select metals/mining stocks ticking higher:
VALE +2.1%, MT +1.8%, RIO +1.5% (Some RIO mines may be purchased by Coal India, according to reports), BBL +1.3%, BHP +0.9%.
Select Japan related names ticking higher after the BOJ has announced a open-ended bond purchase plan:
SMFG +5.2%, NMR +5.1%, TM +3.5%, MTU +3.4%, HMC +3%.
A few telcom names are higher:
TEF +2.4%, TI +2.1%, FTE +1.1%
NAVB +6.7% (Navidea Biopharmaceuticals reports positive top-line results from interim analysis of Lymphoseek Phase 3 clinical trial in head and neck cancer), RDY +3.2% (light volume, Dr. Reddy's launches Zoledronic Acid Injection), FB +0.6% (ahead of expected Android launch), .
NKA +6.9% (light volume, upgraded to Outperform from Market Perform at Wells Fargo, upgraded to Equal Weight from Underweight at Barclays), PT +6.3% (added to Conviction Buy at Goldman), PANL +3.1% (upgraded to Buy at Needham), FNSR +3.1% (upgraded to Buy from Neutral at Lazard), SRPT +2.8% (initiated with Outperform at Baird), PNRA +2.1% (added to Conviction Buy list at Goldman), TMH +1.8% (added to Conviction Buy list and upgraded from Neutral at Goldman ), BRO +1.5% (ticking higher, upgraded to Neutral from Sell at Goldman), EAT +0.8% (upgraded to Buy from Neutral at Goldman), AAPL +0.4% (initiated with a Buy at Lazard)
In reaction to disappointing earnings/guidance:
CPWR -2.7%, MIND -2.5%, LULU -1.5%.
Select gold/silver names showing early weakness:
KGC -1.4%, EGO -1.1%, GOLD -1.0%, SLV -0.8%, GLD -0.7%, GDX -0.5%.
A few European drug names are lower:
NVS -1.3%, AZN -1.1%
MACK -7.4% (announces top-line results from a single arm Phase 2 advanced lung cancer study in patients with resistance to an anti-EGFR tyrosine kinase inhibitor — one cohort of a Phase 2 non-small cell lung cancer study did not meet its primary endpoint), LSE -2.4% (announced the commencement of a public offering of 6,500,000 shares of its common stock), STM -2.2% and ARMH -1.9% (still checking), CCL -1.9% (continued weakness on Triumph news), DEO -1.4% (still checking), RDS.A -0.6% (Royal Dutch Shell Geelong Australia refinery is now for sale, according to reports ).
LCC -1.8% (downgraded to Neutral from Buy at BofA/Merrill), ARUN -1.8% (downgraded to Neutral from Buy at UBS), AVA -1% (ticking lower, downgraded to Neutral from Buy at UBS), MSFT -0.6% (downgraded to Neutral from Buy at BofA/Merrill)
Торговые идеи NYSEи NASDAQ:
– компания понизила прогноз по EPS и выручке на 4 квартал. Лонг выше 11.75, ниже 11.50 смотрим акцию в шорт с потенциалом от 25 до 50 центов.
– компания из индекса SP500. На премаркете небольшой гэп вниз, ниже 32.75 смотрим акцию в шорт.
– смешанный отчет, ожидают FY13 таким же как FY12. Премаркет малоактивный, но на открытии возможна хорошая волатильность. Ключевой уровень – вчерашний максимум 23.00 и минимум 21.50.
Оригинал статьи: http://shark-traders.com/blog/analitika-na-04-04/